This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
Yesterday’s UK 100 Leaders | Price (p) | % Chg |
ANTOFAGASTA PLC | 1,714.5 | 4.8% |
HIKMA PHARMACEUTICALS PLC | 2,392.0 | 2.4% |
ROLLS-ROYCE HOLDINGS PLC | 102.3 | 2.4% |
NATIONAL GRID PLC | 864.6 | 1.9% |
B&M EUROPEAN VALUE RETAIL SA | 601.0 | 1.9% |
Yesterday’s UK 100 Laggards | Price (p) | % Chg |
HARGREAVES LANSDOWN PLC | 1539.5 | -6.9% |
M&G PLC | 187.3 | -5.1% |
BRITISH AMERICAN TOBACCO PLC | 2640.0 | -4.0% |
POLYMETAL INTERNATIONAL PLC | 1551.0 | -3.6% |
AVAST PLC | 489.8 | -3.5% |
Major World Indices | Price | % Chg | 1 YEAR |
UK 100 INDEX | 6,711 | -0.6% | -9.1% |
DOW JONES INDUS. AVG | 31,613 | 0.3% | 8.1% |
DAX INDEX | 13,909 | -1.1% | 1.7% |
NIKKEI 225 | 30,236 | -0.2% | 30.4% |
S&P/ASX 200 INDEX | 6,886 | 0.0% | -3.2% |
Commodities | Units | Price | % Chg |
WTI Crude Oil (Nymex) | USD/bbl. | 61.53 | 0.64% |
Brent Crude (ICE) | USD/bbl. | 64.89 | 0.85% |
Gold Spot | USD/t oz. | 1,783 | 0.4% |
Copper (Comex) | USd/lb. | 391 | 2.3% |
UK 100 is called to open -10 points this morning at 6700. Calls for a slightly weaker open come on the morning of the biggest ex-dividend impact so far of 2021, 12.3 points came of the index this morning in the shape of dividends. Crude oil prices rose further overnight due to a recent cold snap in the United States and causing demand to creep higher. Stateside yesterday saw a mixed session on Wall Street. The Dow Jones closed the session higher, rising 90 points or 0.29% to 31,613, whilst the S&P was more or less flat ending the day at 3,931. The Nasdaq, meanwhile, swung to an 82 point or 0.58% decline with a close of 13,965. In Asia, this morning, Japan’s Nikkei closed slightly lower, by 0.19% to trade at 30,236 as Hong Kong’s Hang Seng pulled back 1.13% to 30,732. The Shanghai Composite meanwhile moved up, rising 0.56%.
Barclays reports that they have resumed paying dividends as their annual profit halved to £3.1bn, which was better than expected (analysts’ average forecast of £1.96bn) due to strong performance by its investment bank offsetting provisions against bad loans from the economic fallout of COVID-19. They are to resume paying dividends of 1p per share as well as returning capital via a £700m buyback.
Hays says that their H1 performance has been hurt by the coronavirus pandemic as their pretax profit falls 78% to £21.1m.
Hochschild Mining FY pretax profit falls to $62.9m (from $76.8m previously).
Indivior reports that their Q4 pretax loss has narrowed to $14m (from $42m loss last year).
Moonpig expects their annual revenue to double on high demand for its services during the COVID-19 pandemic.
Moneysupermarket reports that their 2020 pretax profit is down 24% to £87.8m (from £116m previously).
Primary Health Properties reports that their FY adjusted earnings per share rose 5.5% to 5.8p as their FY net rental income receivable in the year increased by 13.4% to £131.2m (2019: £115.7m).
Smith & Nephew report that their trading profit is down YoY to $683m ($1.17bn previously).
Citigroup Upgrades Aviva to a Buy from Neutral (8 Buys / 9 Holds / 0 Sells)
Goldman Sachs Initiates coverage of Ashtead with a Buy (7 Buys / 8 Holds / 1 Sell)
Morgan Stanley Upgrades SSP Group to Overweight from Equalweight (7 Buys / 8 Holds / 0 Sells)
Barclays
Hays
Indivior
Moneysupermarket.com
Primary Health Properties
Smith & Nephew
NatWest Group
Segro
TBC Bank Group
ECB Monetary Policy Meeting Accounts
BoE’s Saunders speech
US Housing Starts
US Continuing Jobless Claims
Eurozone Consumer Confidence
UK 100:
Imperial Brands
BP
Pershing Square Holdings
GlaxoSmithKline
Royal Dutch Shell A
Royal Dutch Shell B
UK 250:
Murray Income Trust
GCP Student Living
NextEnergy Solar Fund
BBGI Global Infrastructure S.A.
Impax Environmental Markets
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.